These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4942184)

  • 1. Stimulation of human leukocyte thromboplastic activity by endotoxin.
    Lerner RG; Goldstein R; Cummings G; Lange K
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):145-8. PubMed ID: 4942184
    [No Abstract]   [Full Text] [Related]  

  • 2. The procoagulant activity of granulocytes.
    Saba HI; Herion JC; Walker RI; Roberts HR
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the coagulation factors from V through XIII].
    Yoshida K; Tagawa N
    Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
    [No Abstract]   [Full Text] [Related]  

  • 4. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    Pineo GF; Regoeczi E; Hatton MW; Brain MC
    J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitor of human blood coagulation elicited by thrombin.
    Marciniak E
    J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
    Bańkowski E; Worowski K
    Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
    [No Abstract]   [Full Text] [Related]  

  • 7. BLOOD COAGULATION. VII. COAGULATION II.
    DUGDALE M
    Memphis Mid South Med J; 1963 Jan; 38():19-22. PubMed ID: 14087826
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of procoagulant (tissue thromboplastin) activity in cultured leukocytes.
    Kociba GJ; Loeb WF; Wall RL
    J Lab Clin Med; 1972 May; 79(5):778-87. PubMed ID: 5018741
    [No Abstract]   [Full Text] [Related]  

  • 10. Cofactor of the "lupus anticoagulant".
    Rivard GE; Schiffman S; Rapaport SI
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):554-63. PubMed ID: 4141516
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in diagnosis and treatment of hemophilia and related diseases.
    Langdell AD
    CRC Crit Rev Clin Lab Sci; 1970 Dec; 1(4):585-98. PubMed ID: 4939756
    [No Abstract]   [Full Text] [Related]  

  • 12. MODIFICATIONS OF THE COAGULATION MECHANISM DURING PREGNANCY.
    PHILLIPS LL
    Mod Trends Hum Reprod Physiol; 1963; 15():190-204. PubMed ID: 14115154
    [No Abstract]   [Full Text] [Related]  

  • 13. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS.
    HOAK JC; CONNOR WE; WARNER ED
    J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038
    [No Abstract]   [Full Text] [Related]  

  • 14. Dilution curve studies in prothrombin complex factors deficiencies and abnormalities.
    Girolami A; Brunetti A; DeMarco L; Fioretti D
    Blut; 1974 Aug; 29(2):134-43. PubMed ID: 4851393
    [No Abstract]   [Full Text] [Related]  

  • 15. PLASMA PROTHROMBIN ACTIVATION IN HEMORRHAGIC DISORDERS.
    PENNER JA
    Am J Clin Pathol; 1964 Dec; 42():561-71. PubMed ID: 14239431
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation activity of surface activated plasma in vivo.
    Swedenborg J; Kourias E; Olsson P
    Thromb Res; 1979; 16(1-2):231-7. PubMed ID: 505418
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of glass and anticoagulant concentration on improvement of factor X deficiency tests.
    Honorato R; Ivanovic N; Novoa E
    Thromb Res; 1976 Jun; 8(6):769-75. PubMed ID: 960052
    [No Abstract]   [Full Text] [Related]  

  • 18. Disappearance rates of coagulation factors: transfusion studies in factor-deficient patients.
    Bowie EJ; Thompson JH; Didisheim P; Owen CA
    Transfusion; 1967; 7(3):174-84. PubMed ID: 6025693
    [No Abstract]   [Full Text] [Related]  

  • 19. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.
    Osterud B; Bjørklid E
    Scand J Haematol; 1982 Aug; 29(2):175-84. PubMed ID: 6813961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin utilization in congenital coagulation deficiency states.
    Owen CA; Thompson JH
    Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.